Covestor’s Lyell Immunopharma LYEL Stock Holding History

Covestor’s Portfolio LYEL Stock Details LYEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-4	Closed	–	–	2509
2024 Q4	$0	Buy	4 +2	+100%	+$40	﹤0.01%	2518
2024 Q3	$0	Hold	2	–	–	﹤0.01%	2510
2024 Q2	$0	Hold	2	–	–	﹤0.01%	2527
2024 Q1	$0	Hold	2	–	–	﹤0.01%	2524
2023 Q4	$0	Hold	2	–	–	﹤0.01%	2463
2023 Q3	$0	Hold	2	–	–	﹤0.01%	2444
2023 Q2	$0	Buy	2 +1	+100%	+$55	﹤0.01%	2431
2023 Q1	$0	Hold	1	–	–	﹤0.01%	2342
2022 Q4	$0	Sell	1 -1	-50%	-$99	﹤0.01%	2369
2022 Q3	$0	Hold	2	–	–	﹤0.01%	2336
2022 Q2	$0	Buy	+2	New	+$204	﹤0.01%	2168

Other funds holding LYEL

MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return

Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

Orland Properties Ltd Road Town, Tortola, British Virgin Islands $267M AUM 5.05% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return

venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return